Acelity provides an integrated portfolio of proven solutions to assist with the management of infected wounds. When combined with appropriate good clinical practice, such as debridement and systemic antibiotics. Our products deliver the best outcomes for you, your institution and your patients.
The Science Behind Our Products
Our solutions are built on deep scientific expertise, supported by a large body of clinical evidence.
Every infected wound requires a decisive treatment plan to help rapidly clear the infection and re-establish an environment for healing.
A decisive treatment regime can change the course and cost of infected wound management:
In the average 500-bed hospital, infected wounds add 10 days to the length of stay and $2,185 in treatment costs per day2,3
A 30-day hospital readmission rate of 19.1% for infection ranks among the highest causes for readmission in U.S. hospitals4
Treating patients for Staphylococcus aureus infections, the most commonly identified pathogen in chronic wounds,5 more than triples the average hospital costs of other patients
Explore Products for Infected Wounds
Acelity provides a wide range of Negative Pressure Wound Therapy (NPWT) systems for hospital, community or home treatment. Since its launch in 1995, V.A.C.® Therapy has changed the way wounds are treated. Backed by more published clinical evidence than any other NPWT Systems, V.A.C.® Therapy has become the clinicians' treatment of choice for more than 10 million wounds worldwide.* V.A.C.®Therapy creates an environment that promotes wound healing through the application of negative (vacum) pressure at the wound site. This helps to draw wound edges together, remove infectious materials and promote granulation.
Every wound is different. That is why Acelity provides a comprehensive range of advanced wound dressings to help address each wound’s specific needs. Our product portfolio is the result of over 80 years of experience in developing innovative solutions to help you manage wounds towards healing.
A number of our advanced wound dressings such as PROMOGRAN™ Matrix and PROMOGRAN PRISMA™ Matrixoffer antimicrobial benefits to help infected wounds, while our other advanced wound dressings such as ADAPTIC™ Non-Adhering Dressing serve as a gentle silicone wound contact layer. TIELLE™ Hydropolymer Dressings with LIQUALOCK™ Advanced Absorption Technology offer a moist environment which can be conducive to wound healing.
Education is key to promoting quality of care, particularly when it involves the healthcare community. Our instructional programs – from professional training to continuing education – provide a continuum designed to improve skills and enrich knowledge across all healthcare settings.
1. Zhan C, Miller MR. Excess Length of Stay, Charges, and Mortality Attributable to Medical Injuries During Hospitalization. JAMA 2003 October 8; 290(14): 1868-74.
2. 2011 Data from the Nationwide Inpatient Sample (NIS) database examining data from 1,044 community hospitals located in 40 states, approximating a 20% stratified sample. Results may vary based on individual patient and facility circumstances and conditions ($2,184.78 is result of calculation of mean Costs ($10,050) divided by mean LOS (4.6 days) at http://hcupnet.ahrq.gov/hcupnet.jsp)
3. Weiss AJ, Elixhauser A, Steiner C. Readmissions to U.S. hospitals by procedure, 2010. Statistical brief #154 Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality
(AHRQ) https://www.hcup-us.ahrq.gov/reports/statbriefs/sb154.pdf Accessed April 14, 2015
4. Werdin F, Tennenhaus M, Schaller H-E, Rennekampff H-O. Evidence-based Management Strategies for Treatment of Chronic Wounds. Open Access Journal of Plastic Surgery. Volume 9:169-179. Published June 4, 2009 (www.eplasty.com)
You are leaving acelity.com
You are now leaving the acelity.com web site. Links to other sites are provided as a convenience to users. These sites are not affiliated with Acelity, and Acelity accepts no responsibility for their content.
Copyright 2016,2018, KCI Licensing, Inc. All rights reserved.
The information included in this web site has been prepared for and is intended for viewing by residents of the United States of America. This web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.
The information on this site is intended for healthcare professionals. Patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site, including the risks and benefits of certain products and services that may be discussed on this site.